A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer.
Journal: Acta pharmaceutica Sinica. B
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Wu J, Ji R, Wang L, et al. (2026). "A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer.". Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.07.045